Editas Medicine, Inc.
EDIT
$2.37
$0.2612.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -24.90% | -41.97% | -48.37% | -58.64% | 150.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -24.90% | -41.97% | -48.37% | -58.64% | 150.95% |
| Cost of Revenue | -49.52% | -34.75% | -6.14% | 12.16% | 37.54% |
| Gross Profit | 59.11% | 31.44% | -18.44% | -67.73% | -16.94% |
| SG&A Expenses | -21.66% | -9.42% | 0.06% | 3.35% | -4.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -42.79% | -28.69% | -4.53% | 9.68% | 24.44% |
| Operating Income | 47.63% | 24.51% | -11.89% | -41.22% | -9.52% |
| Income Before Tax | 5.10% | -22.44% | -51.22% | -54.74% | -7.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.10% | -22.44% | -51.22% | -54.74% | -7.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.10% | -22.44% | -51.22% | -54.74% | -7.94% |
| EBIT | 47.63% | 24.51% | -11.89% | -41.22% | -9.52% |
| EBITDA | 48.87% | 25.65% | -12.07% | -42.91% | -9.95% |
| EPS Basic | 7.29% | -20.76% | -44.57% | -39.94% | 5.47% |
| Normalized Basic EPS | 43.91% | 18.79% | -15.22% | -34.01% | 6.20% |
| EPS Diluted | 7.29% | -20.76% | -44.57% | -39.94% | 5.47% |
| Normalized Diluted EPS | 43.91% | 18.79% | -15.22% | -34.01% | 6.20% |
| Average Basic Shares Outstanding | 3.57% | 1.51% | 4.35% | 8.46% | 12.97% |
| Average Diluted Shares Outstanding | 3.57% | 1.51% | 4.35% | 8.46% | 12.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |